Breaking News Instant updates and real-time market news.

2019-11-05 04:55:00 APTV Aptiv $95.61 3.23 (3.50%) 04:55 11/05/19 11/05 04:55 11/05/19 04:55	Aptiv management to meet with Oppenheimer Meetings to be held in Canada on November 4-5 hosted by Oppenheimer.	05 Nov 05 Nov 08 Nov 12 Nov 13 Nov
APTV Aptiv $95.61 3.23 (3.50%) 09/13/19 BOFA 09/13/19 DOWNGRADE BOFA Neutral Asbury Automotive, Adient, Aptiv cut to Neutral from Buy at BofA/Merrill BofA/Merrill analyst John Murphy is taking a "more neutral stance" on the automotive sector to reflect the greater market and macro uncertainty and also cites numerous "swing factors" that include trade and technical issues, even though some of the stocks in the auto group have already come down to "trough valuations". The analyst downgrades Asbury Auto (ABG), Adient (ADNT), and Aptiv (APTV) from Buy to Neutral, and also cuts Lithia Motors (LAD) and Sonic Auto (SAH) from Neutral to Underperform. 10/11/19 FBCO 10/11/19 NO CHANGE FBCO Many auto suppliers likely to cut 2019 guidance due to GM, says Credit Suisse Credit Suisse analyst Dan Levy said he expects many auto suppliers to cut 2019 guidance due to the strike at General Motors (GM), noting that his estimates are below the low end of the guide for American Axle (AXL), Aptiv (APTV), Lear (LEA), Delphi Technologies (DLPH) and Dana (DAN). However, he also thinks investors may look through GM-related guidance cuts and shift focus to 2020, but he also sees risk of negative earnings revisions for next year related to China, Europe, and foreign exchange impacts. 10/15/19 GUGG 10/15/19 INITIATION Target $98 GUGG Buy Aptiv initiated with a Buy at Guggenheim Guggenheim analyst Ali Faghri initiated coverage of Aptiv with a Buy rating and $98 price target. 10/16/19 GUGG 10/16/19 INITIATION GUGG Guggenheim initiates Auto Suppliers with cautious sector view Guggenheim analyst Ali Faghri initiated coverage last night on the Auto Suppliers with a cautious sector view. The automotive sector is facing increasing cyclical pressures globally, says Faghri, who forecasts flat to negative global industry production volumes through 2021. This creates a challenging operating environment for auto suppliers, the analyst tells investors in a research note. Faghri believes Europe represents the most significant risk to the group's outlook, pointing out that his work suggests "macro headwinds and disruptive emissions regulations will significantly impact vehicle demand in the region over the next few years." The analyst initiated coverage of Aptiv (APTV) and Gentex (GNTX) with Buy ratings. For Aptiv, he sees high single-digit organic growth through 2022 driven by active safety and electric vehicle content gains. For Gentex, the analyst sees upside to 2019 consensus due to stronger gross margins and visibility for continued above market growth. Faghri rounded out his coverage with Neutral ratings on BorgWarner (BWA), Delphi Technologies (DLPH), Lear (LEA), Visteon (VC) and Veoneer (VNE).

2019-11-05 04:55:00

APTV

Aptiv

$95.61: 3.23 (3.50%)

04:55

11/05/19

11/05

04:55

11/05/19

04:55

Aptiv management to meet with Oppenheimer

Meetings to be held in Canada on November 4-5 hosted by Oppenheimer.

05
Nov
05
Nov
08
Nov
12
Nov
13
Nov

APTV Aptiv

$95.61: 3.23 (3.50%)

09/13/19: BOFA

10/11/19: FBCO

10/15/19: GUGG

10/16/19: GUGG

TODAY'S FREE FLY STORIES

NXGN NextGen Healthcare $16.83 -1.28 (-7.07%) 19:08 12/12/19 12/12 19:08 12/12/19 19:08 Downgrade	NextGen Healthcare rating change » NextGen Healthcare… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
AMOT Allied Motion $46.79 0.81 (1.76%) 18:57 12/12/19 12/12 18:57 12/12/19 18:57 Hot Stocks	Allied Motion CEO sells 10K shares of common stock » In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
LILA Liberty Latin America $17.56 0.32 (1.86%) , DISCA Discovery $32.36 0.28 (0.87%) … 18:54 12/12/19 12/12 18:54 12/12/19 18:54 Hot Stocks	Liberty Latin America says Dr. John Malone retires from board » Liberty Latin America… LILA Liberty Latin America $17.56 0.32 (1.86%) DISCA Discovery $32.36 0.28 (0.87%) LGF.A Lionsgate $9.99 0.65 (6.96%) LGF.B Lionsgate $9.35 0.7 (8.09%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
HOCPY Hoya Corp. $0.00 (0.00%) , TOSBF Toshiba, also use TOSYY $0.00 (0.00%) … 18:43 12/12/19 12/12 18:43 12/12/19 18:43 Hot Stocks	Hoya to offer JPY12,900 per share in tender offer for Toshiba unit NuFlare » Hoya Corporation (HOCPY)… HOCPY Hoya Corp. $0.00 (0.00%) TOSBF Toshiba, also use TOSYY $0.00 (0.00%) TOSYY Toshiba $0.00 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Dec
ADBE Adobe $305.76 2.01 (0.66%) , SRPT Sarepta $100.39 -1.15 (-1.13%) … 18:42 12/12/19 12/12 18:42 12/12/19 18:42 Hot Stocks	Fly Intel: After Hours Movers » UP AFTER EARNINGS: Adobe… UP AFTER EARNINGS: Adobe (ADBE) up 2.9%. ALSO HIGHER: Sarepta (SRPT) up 28.5% after disclosing FDA approval of VYONDYS 53 injection to treat DMD... Datadog (DDOG) up 1.4% after disclosing Azure integration... Transocean (RIG) up 1.4% after getting contract award for Driller III... Tapestry (TPR) up 1.0% after departure of Kate Spade CEO. DOWN AFTER EARNINGS: Good Times Restaurants (GTIM) down 9.1%... Oracle (ORCL) down 2.6%... Broadcom (AVGO) down 1.4%... Costco (COST) down 1.0%. ALSO LOWER: Centene (CNC) down 1.7% after guiding 2020. Movers as of 18:40ET. ADBE Adobe $305.76 2.01 (0.66%) SRPT Sarepta $100.39 -1.15 (-1.13%) DDOG Datadog $35.75 0.23 (0.65%) RIG Transocean $5.94 0.28 (4.95%) TPR Tapestry $26.35 0.515 (1.99%) GTIM Good Times Restaurants $1.71 0.14 (8.92%) ORCL Oracle $56.47 0.16 (0.28%) AVGO Broadcom $327.39 7.53 (2.35%) COST Costco $297.50 2.28 (0.77%) CNC Centene $58.52 -0.13 (-0.22%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec 12 Dec 12 Dec 12 Dec 12 Dec 13 Dec 23 Jan 23 Mar

SRPT Sarepta $100.39 -1.15 (-1.13%) 18:40 12/12/19 12/12 18:40 12/12/19 18:40 Hot Stocks	Breaking Hot Stocks news story on Sarepta » Sarepta up 28.5% after… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
PHR Phreesia $28.67 0.1 (0.35%) 18:38 12/12/19 12/12 18:38 12/12/19 18:38 Syndicate	Phreesia 6.75M share Secondary priced at $26.00 » The deal size was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Dec
SRPT Sarepta $100.39 -1.15 (-1.13%) 18:31 12/12/19 12/12 18:31 12/12/19 18:31 Hot Stocks	Breaking Hot Stocks news story on Sarepta » Sarepta to resume trading… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ADBE Adobe $305.76 2.01 (0.66%) 18:25 12/12/19 12/12 18:25 12/12/19 18:25 Hot Stocks	Adobe CEO: We are not overly concerned with the trade war with China » Comment from interview… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec 23 Jan
SRPT Sarepta $100.39 -1.15 (-1.13%) 18:20 12/12/19 12/12 18:20 12/12/19 18:20 Hot Stocks	Sarepta announces FDA approval of VYONDYS 53 injection to treat DMD » Sarepta Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

AMZN Amazon.com $1,760.44 11.33 (0.65%) 18:11 12/12/19 12/12 18:11 12/12/19 18:11 Hot Stocks	Amazon orders fourth season of 'The Marvelous Mrs. Maisel' » Amazon Studios announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
OHAI OHA Investment $1.28 (0.00%) , PTMN Portman Ridge Finance $2.04 (0.00%) 18:10 12/12/19 12/12 18:10 12/12/19 18:10 Hot Stocks	OHA Investment obtains stockholder approval of Portman Ridge deal » OHA Investment… OHAI OHA Investment $1.28 (0.00%) PTMN Portman Ridge Finance $2.04 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ONCT Oncternal Therapeutics $4.62 0.05 (1.09%) 18:05 12/12/19 12/12 18:05 12/12/19 18:05 Hot Stocks	Oncternal presents interim data from Phase 1b clinical study of cirmtuzumab » Oncternal Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
HZN Horizon Global $3.49 0.14 (4.18%) 18:03 12/12/19 12/12 18:03 12/12/19 18:03 Hot Stocks	Horizon Global CFO Jamie Pierson steps down » Horizon Global announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ORCL Oracle $56.47 0.16 (0.28%) 18:03 12/12/19 12/12 18:03 12/12/19 18:03 Hot Stocks	Oracle CEO Catz says expects momentum in 2H20 to carry into FY21 » Says feels "very… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec

SRPT Sarepta $100.39 -1.15 (-1.13%) 18:00 12/12/19 12/12 18:00 12/12/19 18:00 Hot Stocks	Breaking Hot Stocks news story on Sarepta » Sarepta trading halted,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ORCL Oracle $56.47 0.16 (0.28%) 17:52 12/12/19 12/12 17:52 12/12/19 17:52 Hot Stocks	Oracle's Ellison says 'we have no plans for having a second CEO' » Says there won't be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
NLNK NewLink Genetics $1.61 -0.015 (-0.93%) , EVRC Evercel, Inc $0.00 (0.00%) 17:41 12/12/19 12/12 17:41 12/12/19 17:41 Hot Stocks	NewLink Genetics advances over 11% after Evercel discloses rejected offer » Shares of NewLink… NLNK NewLink Genetics $1.61 -0.015 (-0.93%) EVRC Evercel, Inc $0.00 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EVRC Evercel, Inc $0.00 (0.00%) , NLNK NewLink Genetics $1.61 -0.015 (-0.93%) 17:36 12/12/19 12/12 17:36 12/12/19 17:36 Hot Stocks	Evercel announces rejected offer to acquire NewLink Genetics » Evercel (EVRC) has made… EVRC Evercel, Inc $0.00 (0.00%) NLNK NewLink Genetics $1.61 -0.015 (-0.93%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
BXRX Baudax Bio $6.30 0.225 (3.70%) 17:34 12/12/19 12/12 17:34 12/12/19 17:34 Hot Stocks	Corsair Capital reports 8.77% passive stake in Baudax Bio » Corsair Capital disclosed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Dec

GVA Granite Construction $27.55 1.255 (4.77%) 17:33 12/12/19 12/12 17:33 12/12/19 17:33 Hot Stocks	Granite Construction subsidiary awarded $16M contract to rehabilitate I-94 » Granite Construction… Granite Construction announced that its wholly-owned subsidiary, Kenny Construction, has been awarded a $16M contract by the Illinois Department of Transportation to rehabilitate sections of Interstate 94 at Montrose Avenue in Cook County, Illinois. The project will replace the superstructure and rehabilitate the substructure of I-94 at Montrose Avenue including improvements to drainage and safety with new roadway and underdeck lighting. Construction is expected to begin in early 2020 and be complete in the fall of 2020. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ENV Envestnet $71.58 -0.195 (-0.27%) 17:29 12/12/19 12/12 17:29 12/12/19 17:29 Syndicate	Breaking Syndicate news story on Envestnet » Envestnet files to sell… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
LULU Lululemon $224.48 -8.83 (-3.78%) 17:28 12/12/19 12/12 17:28 12/12/19 17:28 Syndicate	Lululemon holder Advent said to offer 2.6M shares, Bloomberg reports » Block offer range seen at… Block offer range seen at $218.50-$220. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ORCL Oracle $56.47 0.16 (0.28%) 17:26 12/12/19 12/12 17:26 12/12/19 17:26 Hot Stocks	Oracle sees FY20 CapEx approximately $2.2B » Sees FY20 tax rate… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
ORCL Oracle $56.47 0.16 (0.28%) 17:25 12/12/19 12/12 17:25 12/12/19 17:25 Earnings	Oracle sees 'double digit' EPS growth in FY20, consensus $3.88 » Sees FY20 revenue growing… Sees FY20 revenue growing "faster" than FY19, consensus $40.09B. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec

Events

Earnings calls, analyst events, roadshows and more

Tomorrow at 00:00

European Multi-Industry Field Trip Conferences

Europe
Tomorrow at 00:00

Fish & Chips: Semiconductor & Networking Bus Tour Conferences

San Jose, CA
Tomorrow at 00:00

8th Annual ROTH Deer Valley Conference Conferences

Deer Valley, UT
BLRX
Tomorrow at 00:00

ESMO Immuno-Oncology Congress 2019 Conferences

Geneva
QLYS ...
Tomorrow at 00:00

17th Semi-Annual Silicon Valley Technology Bus Tour Conferences

Silicon Valley, CA
SONVY
Tomorrow at 00:00

8th Annual European Healthcare Field Trip Conferences

Basel/Zurich
Tomorrow at 00:00

Atlanta Bank Field Trip Conferences

Atlanta, GA
CRBP
Tomorrow at 00:00

Expert Symposium on Therapeutic Potential of Targeting Endocannabinoid System Conferences

Video Webcast
ATNX
Tomorrow at 00:00

San Antonio Breast Cancer Symposium 2019 Conferences

Henry B. Gonzalez Convention Center, San Antonio, TX
Tomorrow at 00:00

Greater China Corporate Day Conferences

Nomura NY Worldwide Plaza, New York, NY

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CRWD X CRWD Crowdstrike Block Trade Managers: Goldman Sachs Priced at: $49.40 2.2M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AUPH X AUPH Aurinia Pharmaceuticals Secondary Managers: Jefferies & SVB Leerink, H.C. Wainwright, Oppenheimer, Bloom Burton Priced at: $15.00 11.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XAIR X XAIR Beyond Air Secondary Managers: SunTrust, National Securities, Roth Capital, Laidlaw Priced at: $3.66 2.325M Shares ABR X ABR Arbor Realty Spot Secondary Managers: JPMorgan, JMP Securities & Raymond James Priced at: $14.14 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CFRX X CFRX ContraFect Spot Secondary Managers: Maxim Priced at: $.27 37.15M Shares RHP X RHP Ryman Hospitality Spot Secondary Managers: BofA/Merrill, JPMorgan & Wells Fargo Priced at: $85.60 3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SCYX X SCYX Scynexis Spot Secondary Managers: H.C. Wainwright Priced at: $.90 38.89M Shares
Tues	XP X XP XP IPO Managers: Goldman Sachs, JPMorgan, Morgan Stanley, XP & Itau BBA, BofA/Merrill, Citi, Credit Suisse, UBS Priced at: $27.00 72.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CNST X CNST Constellation Pharmaceuticals Spot Secondary Managers: JPMorgan, Jefferies & Cowen, RBC Capital, SunTrust Priced at: $34.50 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GMRE X GMRE Global Medical REIT Spot Secondary Managers: Stifel, BMO Capital, Baird, KeyBanc & SunTrust Priced at: $13.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Jaffray & Stifel, BTIG, JMP Securities, SunTrust Priced at: $36.50 1.57M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDGL X MDGL Madrigal Pharmaceuticals Spot Secondary Managers: Goldman Sachs Priced at: $107.85 1.2M Shares MRNS X MRNS Marinus Pharmaceuticals Spot Secondary Managers: Oppenheimer & Ladenburg Priced at: $1.25 28M Shares PACK X PACK Ranpak Holdings Spot Secondary Managers: Craig-Hallum Priced at: $6.50 15.384M Shares PMT X PMT PennyMac Mortgage Spot Secondary Managers: Morgan Stanley, Credit Suisse, BofA/Merrill, JPMorgan & Barclays, Nomura Instinet, Piper Jaffray Priced at: $22.10 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCKT X RCKT Rocket Pharmaceuticals Spot Secondary Managers: JPMorgan, Cowen & Evercore ISI, LifeSci Priced at: $22.25 3.82M Shares
Wed	BILL X BILL Bill.com IPO Managers: Goldman Sachs, BofA/Merrill, Jefferies & KeyBanc, Canaccord, Needham, William Blair Priced at: $22.00 9.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EH X EH Ehang IPO Managers: Morgan Stanley, Needham, Tigress Financial, Prime Number Priced at: $12.50 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LVGO X LVGO Livongo Health Secondary Managers: Morgan Stanley, Goldman Sachs & JPMorgan Priced at: $27.00 2.78M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MNRL X MNRL Brigham Minerals Secondary Managers: Credit Suisse, Goldman Sachs & RBC Capital Priced at: $18.10 11M Shares MNTA X MNTA Momenta Secondary Managers: Goldman Sachs & JPMorgan, Stifel Priced at: $15.50 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AKTS X AKTS Akoustis Spot Secondary Managers: Craig-Hallum, Roth Capital, Loop Capital Priced at: $6.25 4.8M Shares ASMB X ASMB Assembly Biosciences Spot Secondary Managers: Jefferies & SVB Leerink Priced at: $16.50 5.152M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FTSV X FTSV Forty Seven Spot Secondary Managers: Morgan Stanley & Credit Suisse Priced at: $35.00 4.86M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HCCO X HCCO Healthcare Merger Corp. IPO Managers: Cantor Fitzgerald Priced at: $10.00 22M Shares
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	OCFT X OCFT OneConnect IPO Managers: Morgan Stanley, Goldman Sachs, JPMorgan & Ping An of China, BofA/Merrill, HSBC, CLSA, KeyBanc $9.00-10.00 26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SPT X SPT Sprout Social IPO Managers: Goldman Sachs, Morgan Stanley, KeyBanc & William Blair, Canaccord, Stifel $16.00-18.00 8.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AQST X AQST Aquestive Therapeutics Secondary Managers: BMO Capital $7.51 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Aptiv management to meet with Oppenheimer

TODAY'S FREE FLY STORIES

Get Full Fly Access